NCT05007496View on ClinicalTrials.gov

Preventive Dendritic Cell Vaccine, AV-COVID-19, in Subjects Not Actively Infected With COVID-19

PHASE2CompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

April 14, 2021

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
COVID-19
Interventions
BIOLOGICAL

AV-COVID-19

DCL previously loaded with varying quantity of S-protein

Trial Locations (1)

Unknown

RSPAD Gatot Soebroto, Jakarta

Sponsors
All Listed Sponsors
collaborator

PT AIVITA Biomedika Indonesia

UNKNOWN

collaborator

Kariadi Hospital

UNKNOWN

collaborator

Central Army Hospital RSPAD Gatot Soebroto

UNKNOWN

lead

Aivita Biomedical, Inc.

INDUSTRY

NCT05007496 - Preventive Dendritic Cell Vaccine, AV-COVID-19, in Subjects Not Actively Infected With COVID-19 | Biotech Hunter | Biotech Hunter